期刊
IMMUNOLOGICAL REVIEWS
卷 264, 期 1, 页码 288-307出版社
WILEY
DOI: 10.1111/imr.12252
关键词
tuberculosis; immunopathology; lesion dynamics; biomarkers; animal models
类别
资金
- TB Drug Accelerator program of the Bill and Melinda Gates Foundation
- NIH/NIAID IDIQ Contract [HHSN272201000009I/01]
- Intramural Research Program of the NIH, NIAID
- NIH [1R01AI111967-01, 1R01AI106398-01]
Tuberculosis (TB) lesions are extremely complex and dynamic. Here, we review the multiple types and fates of pulmonary lesions that form following infection by Mycobacterium tuberculosis and the impact of this spatial and temporal heterogeneity on the bacteria they harbor. The diverse immunopathology of granulomas and cavities generates a plethora of microenvironments to which M.tuberculosis bacilli must adapt. This in turn affects the replication, metabolism, and relative density of bacterial subpopulations, and consequently their respective susceptibility to chemotherapy. We outline recent developments that support a paradigm shift in our understanding of lesion progression. The simple model according to which lesions within a single individual react similarly to the systemic immune response no longer prevails. Host-pathogen interactions within lesions are a dynamic process, driven by subtle and local differences in signaling pathways, resulting in diverging trajectories of lesions within a single host. The spectrum of TB lesions is a continuum with a large overlap in the lesion types found in latently infected and active TB patients. We hope this overview will guide TB researchers in the design, choice of read-outs, and interpretation of future studies in the search for predictive biomarkers and novel therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据